» 2004 Lawyers - Personal Injury, Plaintiffs Attorneys - GPWLaw News

Archive for 2004

FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex

December 17th, 2004. (Press Release) The FDA today released the following statement on the halting of a clinical trial of the Cox-2 inhibitor Celebrex (celecoxib): The Food and Drug Administration (FDA) learned last night from the National Cancer Institute (NCI) and Pfizer, Inc., that NCI has stopped drug administration in an ongoing clinical trial ... [More >>]

Posted in Bextra, Celebrex, Harmful Drug Exposure, Personal Injury, Product Liability

Merck & Co., Inc. Response to an Editorial Posted on the New England Journal of Medicine Web Site

December 8th, 2004. In response to an editorial that appeared today on the New England Journal of Medicine website, Merck & Co., Inc. believes that it is important to emphasize that the company promptly and appropriately disclosed the results of the VIGOR (VIOXX Gastrointestinal Outcomes Research) study. Merck correctly communicated about the benefits ... [More >>]

Posted in Harmful Drug Exposure, Personal Injury, Product Liability, Vioxx

Vioxx drug recall; pain and arthritis drug shown to increase risks of stroke, heart attack

September 30th, 2004. Results of a recent study on Vioxx confirmed long-standing concerns that the drug increases the risk of stroke and heart attack, spurring maker Merck to voluntarily pull the drug worldwide (in some countries, the drug is marketed under the name "Ceoxx"). Vioxx is regularly prescribed for treatment of arthritis and acute ... [More >>]

Posted in Harmful Drug Exposure, Personal Injury, Product Liability, Vioxx

FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws the Product

September 30th, 2004. (Press Release) The Food and Drug Administration (FDA) today acknowledged the voluntary withdrawal from the market of Vioxx (chemical name rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufactured by Merck & Co. FDA today also issued a Public Health Advisory to inform patients of this action and to advise them to consult with ... [More >>]

Posted in Harmful Drug Exposure, Personal Injury, Product Liability, Vioxx

Merck Announces Voluntary Worldwide Withdrawal of VIOXX®

September 30th, 2004. Merck & Co., Inc. today announced a voluntary worldwide withdrawal of VIOXX® (rofecoxib), its arthritis and acute pain medication. The company's decision, which is effective immediately, is based on new, three-year data from a prospective, randomized, placebo-controlled clinical trial, the APPROVe (Adenomatous Polyp Prevention on VIOXX) trial. The trial, which ... [More >>]

Posted in Harmful Drug Exposure, Personal Injury, Product Liability, Vioxx

Jury awards $6 million to Shaler couple for asbestos injuries

February 3rd, 2004. From the Pittsburgh Post Gazette: A jury has awarded $6 million to a Shaler couple for injuries the husband received after repeated exposure to asbestos. The Common Pleas Court jury ordered DeZurik Inc. of Sartell, Minn., to pay the money to William and Lois Lisac. ... [More >>]

Posted in Asbestos & Mesothelioma Lawsuits, Personal Injury, Toxic Torts/Harmful Chemical Exposures

Copyright 2003 Goldberg, Persky & White, P.C. The information provided by or linked to from this web site is intended to educate and inform victims of asbestos-related disease and other occupational injuries. The Goldberg, Persky & White, P.C. web site is intended for informational purposes only and is not to be construed as medical or legal advice. Visitors who are in need of legal or medical advice should consult with a professional licensed in their state of residence. The opinions expressed herein by persons or organizations other than Goldberg, Persky & White, P.C. are not necessarily endorsed by Goldberg, Persky & White, P.C. No attorney-client relationship is established by visiting our website or sending us Email. Copyright (c) 2003, Goldberg, Persky & White, P.C. All Rights Reserved.